Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to predict Crohn's treatment success with simple scans

NCT ID NCT07246460

Recruiting now Knowledge-focused Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Dec 10, 2025 · Last updated Jun 16, 2026 · Updated 22 times

Summary

This study looks at how well the drug guselkumab works in adults with Crohn's disease. Researchers will use intestinal ultrasound and blood tests to measure response over one year. The goal is to find better ways to track treatment success without invasive procedures. About 90 participants will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE OF BOTH SMALL AND LARGE INTESTINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • University of Calgary

    RECRUITING

    Calgary, Alberta, T3H 1S7, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Constriction, Pathologic Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN'S DISEASE OF BOTH SMALL AND LARGE INTESTINE